Evista (Raloxifene HCI) Lowers Risk of Invasive...

Evista (raloxifene) is a drug that has been used for treatment of osteoporosis in postmenopausal women. The FDA has also approved it for prevention of invasive breast cancer. Evista creates an estrogen blockade, which lowers the incidence of estrogen-sensitive breast cancer. Learn more about Evista - uses, side effects, and benefits.
Source: About.com Breast Cancer - Category: Cancer & Oncology Authors: Tags: health Source Type: news